In this prospective , double-blind , parallel-group clinical trial , @ consecutive subjects with MOH were randomized ( simple randomization using computer-generated numbers ) for treatment with either @mg/day celecoxib ( for the first @ days then decreased at a rate of @mg every @ days ) or prednisone @ mg/day orally ( for the first @ days then tapered off every @ days ) .